AEGIS LLC
AEGIS LLC is named as the registrant in 2 lobbying reports we hold for 2026-Q2, for 2 clients. 0 reports of 2 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2026-Q2: $60,000 in income | 1 |
| TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRIS | 2026-Q2: $50,000 in income | 1 |
Lobbyists named in these reports
- ANNE ELIZABETH ESPOSITO · 2 reports · earlier government job reported
Bills named, and how the House and the Senate voted
8 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 830SAFE Act | Introduced | No recorded vote in our record |
| H.R. 1227Alternatives to PAIN Act | Introduced | No recorded vote in our record |
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 5376Impacts and Outcomes for Health Career Training Act | Introduced | No recorded vote in our record |
| H.R. 5378Tribal Healthcare Careers Act | Introduced | No recorded vote in our record |
| H.R. 6283FOSTER Act | Introduced | No recorded vote in our record |
| S. 475Alternatives to PAIN Act | Introduced | No recorded vote in our record |
| S. 1542Uyghur Policy Act of 2026 | Reported by committee | No recorded vote in our record |
Issues named: Pharmacy (2), Health Issues (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRISPharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPharmacy, Health Issues | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.